Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | 4.1% | 5.3% | 5.9% | 7.4% | 9.9% | 8.9% | 14.2% | 14.2% | 16.4% | 15.8% | 3.4% | 23.9% | 23.2% | 15.7% | 14.0% | 22.2% | 32.8% | 20.4% | 25.1% | 18.0% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is 17.0%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Edwards Lifesciences Corporation have been 21.5% over the past three years, and 21.0% over the past five years.
As of today, Edwards Lifesciences Corporation's ROIC - WACC is 17.0%, which is higher than industry median of (64.5%). It indicates that Edwards Lifesciences Corporation's ROIC - WACC is Good.